Your session is about to expire
← Back to Search
iREACH CDS Tool for Preventing Peanut Allergy (iREACH Trial)
iREACH Trial Summary
This trial will assess whether an electronic health record-based tool can help doctors better adhere to guidelines around preventing peanut allergies, with the goal of reducing the incidence of peanut allergies.
iREACH Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.iREACH Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My infant has seen a pediatrician for a 4 or 6-month wellness check.I can understand the study details and agree to participate in surveys when my child is 12 and 24 months old.My practice sees fewer than 50 newborn patients a year.I provide routine care for infants who are 4 or 6 months old.The infant has other medical conditions or test results that could make it unsafe or difficult to follow the study guidelines.I am over 18 years old or have permission to participate.My infant cannot eat by mouth due to a long-term health issue.
- Group 1: Intervention (CDS Tool Integrated)
- Group 2: Control (No CDS Tool Integrated)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this investigation accepting new recruits?
"According to clinicaltrials.gov, this research endeavor is no longer actively recruiting participants as it was last updated on July 8th 2022. Despite its conclusion, there are still 264 other trials accepting applicants at the moment."
Are there multiple medical sites in Canada presently administering this research study?
"There are a total of 36 locations for this study, scattered across Wilmette, Peoria and Morton to name a few. To reduce the burden of traveling far distances, it is advised that those interested in participating select the trial site nearest them."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger